Promising Atopic Dermatitis Treatment
Promising Atopic Dermatitis Treatment A major force in the atopic dermatitis (AD) space is Topical Janus kinase (JAK) inhibitors. Recently, an increasing number of JAK agents are filling the early and late-stage pipeline. Ramla Salad, Pharma Analyst at Global Data, comments "JAK inhibitors can combat AD at the immune system level due to their broad inhibitory effect. They are being developed in both oral and topical formulations, which target both mild-to-moderate and moderate-to-severe respectively". Thus, targeting an array of patient groups to tolerate the topical agents for mild-to-mode...